FTUS
GILD icon

Flow Traders U.S.’s Gilead Sciences GILD Stock Holding History

Flow Traders U.S.’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Buy
+2,384
New +$314K 0.01% 792
2025
Q1 		– Sell
-3,343
Closed -$309K – 1073
2024
Q4 		$309K Buy
+3,343
New +$301K 0.01% 744
2017
Q1 		– Sell
-200
Closed -$14K – 383
2016
Q4 		$14K Buy
+200
New +$14.9K ﹤0.01% 407

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Flow Traders U.S.'s GILD Position: Q2 2026 in Review

Flow Traders U.S. opened a new position in Gilead Sciences (GILD) in Q2 2026: 2,384 shares worth $301K. The stake represents 0.01% of the portfolio and ranks #792 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in GILD as recently as Q4 2024.

Flow Traders U.S. first reported a position in GILD in Q4 2016 and has held it in 3 quarters since. The position peaked at $309K in Q4 2024. 2,289 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Flow Traders U.S. held 2,384 shares of Gilead Sciences worth $301K as of Q2 2026.
  • Gilead Sciences was a new Flow Traders U.S. position in Q2 2026.
  • Gilead Sciences made up 0.01% of Flow Traders U.S.'s portfolio in Q2 2026, its #792 holding.
  • Flow Traders U.S. first reported a position in Gilead Sciences in Q4 2016 and has held it in 3 quarters since.
  • Flow Traders U.S.'s Gilead Sciences position peaked at $309K in Q4 2024.
  • 2,289 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.